EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Breast cancer PDxO cultures for drug discovery and functional precision oncology

Sandra D Scherer, Ling Zhao, Andrew J Butterfield, Chieh-Hsiang Yang, Emilio Cortes-Sanchez, Katrin P Guillen, Bryan E Welm, Alana L Welm

STAR Protocols · 2023-09 · 4 (3) · 102402

DOI: 10.1016/j.xpro.2023.102402 ↗

Kurz gefasst

Fachartikel in der Zeitschrift STAR Protocols, 2023-09. Verfasst von Sandra D Scherer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA; Department of Oncological Sciences, University of …. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute, Breast Cancer Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patient-derived xenografts (PDXs) have clinical value but are time-, cost-, and labor-intensive and thus ill-suited for large-scale experiments. Here, we present a protocol to convert PDX tumors into PDxOs for long-term cultures amenable to moderate-throughput drug screens, including in-depth PDxO validation. We describe steps for PDxO preparation and mouse cell removal. We then detail PDxO validation and characterization and drug response assay. Our PDxO drug screening platform can predict therapy response in vivo and inform functional precision oncology for patients. For complete details on the use and execution of this protocol, please refer to Guillen et al.1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansAnimalsMiceFemalePrecision MedicineDrug DiscoveryDrug Evaluation, Preclinical

Stichwörter der Autor:innen

CancerCell CultureCell-based AssaysModel OrganismsOrganoids

Autor:innen und Institutionen

  • Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA; Department of Oncological Sciences, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA.
  • Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA; Department of Surgery, University of Utah, 30 N 1900 E, Salt Lake City, UT 84132, USA. Electronic address: bryan.welm@hc…
  • Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA; Department of Oncological Sciences, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA. Electronic a…

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • Breast Cancer Research Foundation
  • Huntsman Cancer Foundation
  • NIH
  • University of Utah
  • California Breast Cancer Research Program
  • DOD

Zitieren

APA

Scherer, S. D., Zhao, L., Butterfield, A. J., Yang, C. H., Cortes-Sanchez, E., Guillen, K. P., Welm, B. E., & Welm, A. L. (2023). Breast cancer PDxO cultures for drug discovery and functional precision oncology. STAR Protocols, 4(3), 102402. https://doi.org/10.1016/j.xpro.2023.102402

Vancouver

Scherer SD, Zhao L, Butterfield AJ, Yang CH, Cortes-Sanchez E, Guillen KP, et al. Breast cancer PDxO cultures for drug discovery and functional precision oncology. STAR Protocols. 2023;4(3):102402. doi:10.1016/j.xpro.2023.102402

BibTeX
@article{Scherer2023,
  author = {Scherer, Sandra D and Zhao, Ling and Butterfield, Andrew J and Yang, Chieh-Hsiang and Cortes-Sanchez, Emilio and Guillen, Katrin P and Welm, Bryan E and Welm, Alana L},
  title = {Breast cancer PDxO cultures for drug discovery and functional precision oncology},
  journal = {STAR Protocols},
  year = {2023},
  volume = {4},
  number = {3},
  pages = {102402},
  doi = {10.1016/j.xpro.2023.102402}
}
Kostenlos starten →